Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea 2019-07-17 21:00
AirXpanders® Announces Reduction in Force and Plan to Cease Operations 2019-07-17 07:17
AirXpanders® Receives FDA 510(k) Clearance for a Smooth Shell Version of the AeroForm® Tissue Expander System 2019-07-15 09:17
Yuyu Pharma held the campaign for enhancing corporate transparency 2019-07-11 16:43
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China 2019-07-11 04:01
VolitionRx Limited Awarded an Additional $1.4 Million in Non-Dilutive Funding 2019-07-10 20:30
Spectrum Therapeutics partners with Canadian Mental Health Association's Not Myself Today® initiative 2019-07-10 20:00
CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST 2019-07-10 10:23
Medeon Led and Completed Investments in Panther Orthopedics and Prodeon 2019-07-08 17:10
New England Biolabs®, Inc. opens eighth subsidiary in Australia 2019-07-03 22:00
China SXT Pharmaceuticals, Inc. Announces TCM Homologous Supplements Production 2019-07-03 20:00
CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019 2019-07-02 06:15
Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation 2019-07-01 19:10
WuXi AppTec Named One of MIT Technology Review's 50 Smartest Companies 2019-06-29 13:26
Saluda Medical Raises $75 Million Equity Financing from Boston Scientific and Redmile Group 2019-06-28 16:00
Saluda Medical Secures Debt Financing From Medtronic 2019-06-27 16:00
Medical Travel Companions (MTC), the Leading Travel Assistance Provider, Joins the HERE Mobility Marketplace 2019-06-27 11:00
I-Mab Announces Dosing of First Patient in a Phase I Clinical Trial of TJC4, a Potentially Differentiated CD47 Antibody, for the Treatment of Cancers in the United States 2019-06-25 22:01
Education Resources, Inc. Unveils New Website And Brand Identity 2019-06-25 06:07
Target Health and dMed Biopharmaceuticals Join Forces to Help Western and Chinese Biopharma and Device Companies 2019-06-25 04:00
1 217 218 219 220 221 430